These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34916301)

  • 1. Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus.
    Giaglis S; Daoudlarian D; Voll RE; Kyburz D; Venhoff N; Walker UA
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34916301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides.
    Giaglis S; Daoudlarian D; Thiel J; Rizzi M; Kyburz D; Venhoff N; Walker UA
    Rheumatology (Oxford); 2023 Aug; 62(8):2930-2937. PubMed ID: 36645235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus.
    Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
    Clin Exp Immunol; 2014 Apr; 176(1):66-77. PubMed ID: 24345202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis.
    Lehmann J; Giaglis S; Kyburz D; Daoudlarian D; Walker UA
    Arthritis Res Ther; 2024 May; 26(1):97. PubMed ID: 38715082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis.
    Lee HT; Lin CS; Chen WS; Liao HT; Tsai CY; Wei YH
    Int J Mol Sci; 2012; 13(7):8853-8868. PubMed ID: 22942739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus.
    Al-Shobaili HA; Rasheed Z
    Lupus; 2013 Sep; 22(10):1024-37. PubMed ID: 23884988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.
    Chen JY; Wang CM; Chang SW; Cheng CH; Wu YJ; Lin JC; Yang B; Ho HH; Wu J
    Arthritis Rheumatol; 2014 Nov; 66(11):3113-21. PubMed ID: 25154742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Plasma Cell-Free Mitochondrial DNA and Nuclear DNA in Systemic Lupus Erythematosus.
    Lee HT; Lin CS; Pan SC; Chen WS; Tsai CY; Wei YH
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):333. PubMed ID: 36624953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus.
    López-López L; Nieves-Plaza M; Castro Mdel R; Font YM; Torres-Ramos CA; Vilá LM; Ayala-Peña S
    Lupus; 2014 Oct; 23(11):1133-41. PubMed ID: 24899636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients.
    Sundquist K; Sundquist J; Hedelius A; Memon AA
    Mol Carcinog; 2020 Dec; 59(12):1362-1370. PubMed ID: 33051887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum phosphatidylserine-specific phospholipase A
    Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
    Liu C; Wang Y; Zhang YH; Yuan Z; Zhang Z; Zeng X; Guan Z; Bahabayi A; Lu S
    Immunol Invest; 2023 Nov; 52(7):879-896. PubMed ID: 37642473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy number.
    Li Z; Zong QQ; Zhai CX; Yu GH; Hu WQ; Wang YH; Wang LL; Yan ZY; Zhang TY; Teng Y; Liu S; Cai J; Li M; Chen YF; Ni J; Cai GQ; Cai PY; Pan HF; Zou YF
    Immunol Res; 2022 Dec; 70(6):850-859. PubMed ID: 36103009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of circulating cell-free DNA are a biomarker of active SLE.
    Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
    Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.